Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Phoenix

Tucson

Little Rock

Costa Mesa

Culver City

Encino

Glendale

Long Beach

Los Alamitos

Orange

Redding

San Diego

New Haven

Norwich

Atlantis

Brooksville

Delray Beach

Fort Myers

Hallandale

Hialeah

Jacksonville

Leesburg

Miami

Orlando

Sunrise

West Palm Beach

Columbus

Park Ridge

Wichita

Baton Rouge

Bangor

Newton

Plymouth

Flowood

Hattiesburg

Creve Coeur

Princeton

Springfield

Albuquerque

Brooklyn

Cedarhurst

Latham

Staten Island

Charlotte

Wilmington

Oklahoma City

Portland

Norristown

Plains

East Providence

San Antonio

Salt Lake City

Bennington

Charlottesville

Williamsburg

Richland

Geelong

Leuven

Kelowna

Halifax

Chatham

Toronto

Prague

Rychnov nad Kněžnou

Milan

Amsterdam

Bialystok

Warsaw

Johannesburg

Pretoria

Durban

Bellville

George

Somerset West

Busan

Incheon

Seoul

Terrassa

Burgos

Madrid

Salamanca

Glasgow

Isleworth

Northampton

Penarth

Southampton